Viewing Study NCT07190833


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-26 @ 1:30 AM
Study NCT ID: NCT07190833
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-24
First Post: 2025-09-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)
Sponsor: Bionoxx Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module